Structural Heart Imaging Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 2.5 billion
Estimated Base Value
2035 Forecast
US$ 4.3 billion
Projected Market Value
CAGR 2026–2035
5.6%
Compound Annual Growth
Largest Segment
Echocardiography
Fastest Growing Segment
Magnetic Resonance Imaging
Leading Region
North America
Fastest Growing Region
Emerging Areas
Top Country
United States
By Market Share
25.1% market share
Key Players
Mindray
Emerging Players
FEops HEARTGuide, Us2.ai
Market Definition & Overview
The Structural Heart Imaging Market encompasses medical devices, software, and services dedicated to visualizing the heart's anatomy and function for the diagnosis, planning, guidance, and post-procedural assessment of structural heart diseases and interventions. This market primarily supports minimally invasive procedures such as Transcatheter Aortic Valve Replacement (TAVR), Mitral Clip implantation, and patent foramen ovale/atrial septal defect (PFO/ASD) closures. It leverages advanced imaging modalities like echocardiography (transthoracic, transesophageal, intracardiac), computed tomography (CT), and magnetic resonance imaging (MRI) to provide detailed anatomical and hemodynamic insights, enhancing procedural safety and efficacy and improving patient outcomes.
Scope
- Global market analysis covering all major geographic regions.
- Focus on imaging devices, software, and associated services.
- Time-period scope from current year to the next 5-7 years for projections.
Inclusions
- Echocardiography systems (TTE, TEE, ICE) specifically used for structural heart interventions.
- Computed Tomography (CT) scanners and software for structural heart pre-procedural planning.
- Magnetic Resonance Imaging (MRI) systems for structural heart assessment and follow-up.
- Advanced visualization and 3D reconstruction software for structural heart procedures.
- Fusion imaging technologies integrating various modalities for real-time guidance.
- Intracardiac Echocardiography (ICE) catheters for procedural guidance.
Exclusions
- General diagnostic cardiac imaging not specific to structural heart interventions.
- Therapeutic structural heart devices (e.g., TAVR valves, LAA occluders).
- Electrophysiology (EP) mapping and ablation systems.
- Imaging for coronary artery disease (e.g., traditional angiography for stents).
- Surgical tools and devices for open-heart structural heart repair.
Market Size Forecast
Executive Summary
• The Structural Heart Imaging market is valued at $2.5 Bn in 2025 and is forecast to reach $4.3 Bn by 2035, reflecting a robust CAGR of 5.6% as demand accelerates across every major segment and region over the ten-year outlook.
• Echocardiography leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• North America commands the largest regional share at 35.0%, while Emerging Areas is expanding the fastest at a 9.0% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at 25.1% of global share, anchoring overall demand within its home region throughout the forecast period.
• Consolidation among key imaging platform developers is accelerating, propelled by the need for comprehensive diagnostic suites and integrated workflows, forcing smaller innovators to seek strategic alliances or risk marginalization in the evolving competitive landscape.
• Advancements in AI-powered image analysis and real-time 3D visualization are significant growth catalysts, enhancing procedural accuracy and expanding the scope of treatable structural heart conditions across global clinical practices.
• Evolving regulatory frameworks in major economies are fostering innovation in novel imaging modalities, concurrently creating regional market access challenges and opportunities based on varying reimbursement policies and clinical guideline adoption.
• The strategic emphasis on transcatheter interventions is elevating demand for advanced intraprocedural imaging, compelling manufacturers to innovate integrated solutions that reduce procedural complexity and improve patient outcomes across diverse structural heart defects.
• Strategic investments are flowing into R&D for next-generation, high-resolution imaging probes and interoperable software platforms, aiming to optimize global supply chain resilience and streamline clinical integration for enhanced operational efficiency.
• The forward-looking outlook indicates a sustained shift towards preventative and early diagnostic imaging, with emerging markets becoming pivotal growth engines driven by increasing healthcare infrastructure investment and rising awareness.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Value
The Structural Heart Imaging Market was valued at $2.5 billion in the base year, reflecting a substantial existing industry.
Market Projection
The market is projected to reach $4.3 billion by the forecast year, indicating significant future expansion.
Consistent Growth Rate
The industry is set for consistent growth, exhibiting a Compound Annual Growth Rate (CAGR) of 5.6% over the forecast period.
Robust Market Expansion
Overall, the Structural Heart Imaging Market is poised for robust expansion, growing from $2.5 billion to $4.3 billion with a 5.6% CAGR.
North American Dominance
North America is expected to maintain its leading position in the market, driven by advanced healthcare infrastructure and high adoption rates of imaging technologies.
AI Integration Trend
A notable trend in the market is the increasing integration of Artificial Intelligence (AI) for enhanced image analysis and diagnostic accuracy in structural heart imaging.
Market Dynamics
Market Trends
- Increasing adoption of AI/ML in image analysis is a key trend.
- Shift towards 3D and 4D real-time imaging modalities is notable.
- Growing integration of imaging with procedural navigation systems.
- Miniaturization of imaging probes for less invasive procedures is rising.
Growth Drivers
- Rising global prevalence of structural heart diseases drives demand.
- Aging population demanding more cardiac interventions fuels growth.
- Technological advancements improve diagnostic accuracy and outcomes.
- Increased awareness and early diagnosis boost market expansion.
Restraints
- High cost of advanced imaging systems limits broader market adoption.
- Shortage of trained specialists for complex image acquisition and interpretation.
- Uncertain or inadequate reimbursement policies hinder market growth and accessibility.
- Rapid technological advancements necessitate frequent and costly equipment upgrades.
Opportunities
- Emerging markets offer significant untapped potential for growth.
- Development of novel non-invasive imaging techniques creates new avenues.
- Personalized medicine approach using advanced imaging holds promise.
- Collaboration between device manufacturers and software developers is key.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | EchocardiographyComputed TomographyMagnetic Resonance ImagingAngiography & FluoroscopyIntravascular Ultrasound & Optical Coherence TomographyFusion ImagingOthers |
| By Technology | 2D Echocardiography3D & 4D EchocardiographyDoppler EchocardiographyStrain & Stress EchocardiographyCardiac Computed Tomography AngiographyCardiac Magnetic Resonance AngiographyIntracardiac EchocardiographyImage Processing & Artificial Intelligence |
| By Application | Valvular Heart Disease AssessmentCongenital Heart Defect DiagnosisCardiomyopathy EvaluationAortic Disease ImagingPre-Procedural Planning & GuidancePost-Procedural AssessmentCardiac Tumor & Pericardial DiseaseOthers |
| By End-User | HospitalsSpecialty Cardiology ClinicsAmbulatory Surgical CentersDiagnostic Imaging CentersResearch & Academic InstitutionsCardiac Catheterization LaboratoriesGovernment Healthcare Facilities |
| By Product | Echocardiography SystemsComputed Tomography SystemsMagnetic Resonance Imaging SystemsAngiography SystemsIntracardiac Echocardiography CathetersImage Analysis & Post-Processing SoftwareContrast AgentsServices |
| By Functionality | Diagnostic ImagingInterventional GuidancePre-Procedural PlanningPost-Procedural AssessmentQuantitative Analysis3D & 4D ReconstructionReal-Time ImagingImage Fusion & Co-Registration |
Regional Analysis
- North America dominates the structural heart imaging market, driven by advanced healthcare infrastructure, high prevalence of structural heart diseases, and strong adoption of cutting-edge diagnostic technologies. Significant R&D investments and favorable reimbursement policies further solidify its leading position.
- Asia-Pacific is projected to be the fastest-growing region for structural heart imaging. This growth is fueled by a burgeoning aging population, rising incidence of cardiovascular diseases, improving healthcare expenditure, and increasing awareness of early diagnosis. Expanding medical infrastructure also contributes significantly.
- An emerging trend in Europe involves the increasing integration of multimodal imaging for comprehensive pre-procedural planning and intra-procedural guidance in structural heart interventions. This focus on precision and personalized treatment, supported by evolving regulatory frameworks, is enhancing patient outcomes and market adoption.
Asia Pacific
8.5% CAGR
$550.0 Mn
22% share
- Experiencing rapid growth fueled by increasing healthcare expenditure, a large patient pool, and improving access to advanced medical technologies.
- Government initiatives and medical tourism further contribute to market expansion.
North America
6.5% CAGR
$875.0 Mn
35% share
- Dominates with high adoption of advanced imaging technologies and a strong presence of key market players.
- Significant R&D investment drives innovation in structural heart disease diagnosis and treatment.
Europe
6.8% CAGR
$700.0 Mn
28% share
- Benefits from a well-established healthcare infrastructure and an aging population prone to structural heart conditions.
- Strict regulatory frameworks ensure high quality and safety standards for imaging devices.
Latin America
7.5% CAGR
$200.0 Mn
8% share
- Shows steady growth driven by increasing awareness of cardiovascular diseases and growing investments in healthcare infrastructure.
- Demand for minimally invasive procedures and diagnostic imaging is on the rise.
Middle East & Africa
7.8% CAGR
$125.0 Mn
5% share
- An emerging market with significant government spending on healthcare infrastructure development and a rising prevalence of lifestyle-related heart conditions.
- Medical tourism also plays a role in technology adoption.
Emerging Areas
9.0% CAGR
$50.0 Mn
2% share
- Represents a nascent market with high growth potential, albeit from a small base, as basic healthcare access and diagnostic capabilities improve.
- Investments are slowly increasing to address unmet medical needs.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $627.5 Mn | 7.8% | As the largest and most technologically advanced healthcare market, the US leads in adoption of structural heart imaging due to high prevalence of cardiovascular diseases and significant R&D investment. |
| 2 | Brazil | $45.0 Mn | 9.5% | As the largest economy in Latin America, Brazil's growing healthcare infrastructure and rising incidence of structural heart diseases make it a significant and expanding market for imaging solutions. |
| 3 | Germany | $122.5 Mn | 6.8% | Germany boasts one of Europe's most advanced and largest healthcare systems, driving high adoption rates for sophisticated structural heart imaging technologies and a strong focus on innovation. |
| 4 | China | $212.5 Mn | 12.5% | China represents a high-growth market driven by a massive population, increasing prevalence of cardiovascular diseases, and significant government investment in healthcare infrastructure and medical devices. |
| 5 | Saudi Arabia | $22.5 Mn | 10.1% | Saudi Arabia's Vision 2030 initiatives are significantly boosting healthcare infrastructure and investment, leading to increased demand for advanced structural heart imaging to address growing cardiovascular health concerns. |
Countries Covered (23)
United States, Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, United Kingdom, France, Italy, Spain, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Mindray | 5.7% | Expand global market presence by offering a broad portfolio of cost-effective, high-quality medical devices across various clinical settings. | Mindray is a leading global developer and manufacturer of medical devices, known for its extensive product range and strong presence in emerging markets. | Mindray recently expanded its ultrasound portfolio with new AI-powered features for enhanced diagnostic accuracy and workflow efficiency. | Resona 7DC-90M9+1 |
| 2 | Esaote S.p.A. | 5.4% | Focus on specialized diagnostic imaging solutions, particularly in ultrasound and dedicated MRI, emphasizing clinical performance and ease of use. | Esaote is a European leader in medical imaging, particularly strong in dedicated MRI and point-of-care ultrasound systems. | Esaote introduced new AI-powered tools for cardiac and vascular ultrasound analysis to improve diagnostic workflows. | MyLab X8MagnificoO-scan+1 |
| 3 | Shimadzu Corporation | 5.1% | Leverage its long-standing expertise in analytical and medical precision instruments to deliver advanced imaging systems that enhance diagnostic capabilities. | Shimadzu is a diversified global manufacturer renowned for its precision instruments across scientific, medical, and industrial fields. | Shimadzu recently launched a new generation of its C-arm fluoroscopy system with improved image quality and reduced dose. | Trinias C16SONARCSONIALVISION G4+1 |
| 4 | Circle Cardiovascular Imaging | 4.9% | Specialize in advanced post-processing software for cardiac MRI and CT, aiming to provide comprehensive and AI-driven solutions for precise diagnosis and quantification. | Circle CVI is a global leader in cardiovascular post-processing software, highly regarded for its comprehensive and robust analysis platforms. | Circle CVI partnered with multiple imaging vendors to integrate its AI-driven post-processing solutions directly into clinical workflows. | cvi42SuiteAIMR Flow+1 |
| 5 | Medis Medical Imaging Systems B.V. | 4.6% | Develop and provide advanced quantitative image analysis software for cardiovascular applications, focusing on accuracy, reproducibility, and clinical research. | Medis is well-known for its quantitative analysis software for cardiovascular imaging, widely used in clinical trials and and clinical settings. | Medis launched new AI-powered modules for advanced strain analysis and plaque characterization in its imaging software suite. | QMassQAngio XAQStrain+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Mindray, Esaote S.p.A., Shimadzu Corporation, Circle Cardiovascular Imaging, Medis Medical Imaging Systems B.V., Pie Medical Imaging B.V., HeartFlow, Inc., Lantheus Holdings, Inc., NANO-X IMAGING LTD, Ultromics Ltd., DiA Imaging Analysis Ltd., EchoPixel, Inc., TeraRecon, Inc., Intrasense SA, Chison Medical Technologies Co., Ltd., Vinno Technology (Suzhou) Co., Ltd., DeepMotion Medical Imaging Inc., Caristo Diagnostics Ltd., Beijing Bohui Innovation Technology Co., Ltd., Intelligent Medical Imaging & Communication Co., Ltd.
The global Structural Heart Imaging market features a competitive landscape led by Mindray, Esaote S.p.A., Shimadzu Corporation, Circle Cardiovascular Imaging, Medis Medical Imaging Systems B.V., and Pie Medical Imaging B.V., among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
Mindray
Esaote S.p.A.
Shimadzu Corporation
Circle Cardiovascular Imaging
Medis Medical Imaging Systems B.V.
Pie Medical Imaging B.V.
HeartFlow, Inc.
Lantheus Holdings, Inc.
NANO-X IMAGING LTD
Ultromics Ltd.
DiA Imaging Analysis Ltd.
EchoPixel, Inc.
TeraRecon, Inc.
Intrasense SA
Chison Medical Technologies Co., Ltd.
Vinno Technology (Suzhou) Co., Ltd.
DeepMotion Medical Imaging Inc.
Caristo Diagnostics Ltd.
Beijing Bohui Innovation Technology Co., Ltd.
Intelligent Medical Imaging & Communication Co., Ltd.
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
GE HealthCare Launches AI-Powered Echo for Structural Heart
GE HealthCare received FDA 510(k) clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems, featuring new AI-driven capabilities to enhance the assessment and planning of structural heart disease procedures. This innovation aims to improve diagnostic accuracy and procedural efficiency.
Philips Unveils Enhanced Azurion System for Complex Structural Heart Cases
Philips introduced significant enhancements to its Azurion image-guided therapy system, specifically designed to optimize workflow and provide superior visualization for complex structural heart interventions. The updates aim to increase precision and safety during procedures.
Siemens Healthineers Receives FDA Clearance for ACUSON Origin Ultrasound System
Siemens Healthineers announced FDA clearance for its ACUSON Origin cardiovascular ultrasound system, purpose-built for interventional cardiology and structural heart procedures. This dedicated system offers advanced imaging capabilities to guide intricate interventions with greater clarity.
Lantheus Invests in Ultromics, Bolstering AI in Echocardiography
Lantheus Holdings, a leader in diagnostics, made a strategic investment in Ultromics, an AI-powered echocardiography company. This collaboration aims to accelerate the development and commercialization of AI solutions for cardiac analysis, particularly impacting structural heart disease diagnosis.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $2.5 Bn |
| Market Size (Forecast) | $4.3 Bn |
| CAGR | 5.6% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 23 Countries |
| Segments Covered | 6 Segments, 46 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included